GAITHERSBURG, Md., May 11, 2016 /PRNewswire-USNewswire/ — With the most recent outbreak of Zika virus and confirmed cases in the Americas, the need for diagnosis can not be overemphasized. The WHO estimates that 3 to 4 million people will contract Zika virus worldwide in the next 12 months and has declared Zika virus infection as a Public Health Emergency of International Concern (PHEIC). Though no locally transmitted cases have been reported within the United States as of yet, currently close to 500 cases of travel-associated cases have already been reported. Like Dengue and Chikungunya viruses, Zika virus is transmitted primarily through the bite of an infected Aedes species mosquito.  Disease has also recently been confirmed to be transmitted through sexual contact. Urgency to diagnose Zika virus is greatest in pregnant women and women of child-bearing age that are planning to start a family and have travelled to or have a partner who has travelled to areas where Zika virus is known to exist. Microcephaly in newborns born to mothers who were infected with Zika virus while pregnant has been confirmed in 9 countries. Since 2007, Zika virus infections have been reported in 61 countries and territories according to the CDC.

2 thoughts on “Clongen Laboratories, LLC to offer Zika, Dengue and Chikungunya virus molecular detection

Comments are closed.